Singapore markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0200-0.0200 (-1.92%)
At close: 04:00PM EST
1.0400 +0.02 (+1.96%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 59.48M
Enterprise value -97.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)14.61
Price/book (mrq)0.33
Enterprise value/revenue -24.41
Enterprise value/EBITDA 0.78

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3-42.37%
S&P500 52-week change 326.89%
52-week high 32.2900
52-week low 30.7310
50-day moving average 31.1360
200-day moving average 31.3584

Share statistics

Avg vol (3-month) 3192.75k
Avg vol (10-day) 3413.65k
Shares outstanding 558.32M
Implied shares outstanding 658.32M
Float 841.94M
% held by insiders 120.23%
% held by institutions 146.13%
Shares short (15 Feb 2024) 4611.57k
Short ratio (15 Feb 2024) 44.79
Short % of float (15 Feb 2024) 41.36%
Short % of shares outstanding (15 Feb 2024) 41.05%
Shares short (prior month 12 Jan 2024) 42.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-3,688.66%

Management effectiveness

Return on assets (ttm)-28.83%
Return on equity (ttm)-53.39%

Income statement

Revenue (ttm)4M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -125.94M
Net income avi to common (ttm)-119.14M
Diluted EPS (ttm)-2.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)186.71M
Total cash per share (mrq)3.2
Total debt (mrq)29.54M
Total debt/equity (mrq)16.54%
Current ratio (mrq)7.46
Book value per share (mrq)3.07

Cash flow statement

Operating cash flow (ttm)-76.09M
Levered free cash flow (ttm)-45.01M